Emerging Company Showcase
The Neurotech Investing & Partnering conference will host our Third Annual Emerging Company Showcase as part of the main conference program. This showcase allows neurotechnology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.
To be eligible to participate, companies must be:
- Addressing an unmet medical need
- Founded no earlier than 2013
- Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2017 are not eligible for this showcase)
To be considered, please submit your information via the form below no later than April 2, 2018. Entries will be reviewed by the scientific advisory board and selected companies will be notified April 15, 2018. Selected companies will receive a discounted registration rate of $500.
Please note that all companies must have a valid email address and phone number to be eligible for participation in the Emerging Company Showcase. A recent news article or webpage from an investor or parent company may be submitted in lieu of a company website.